Otira Pharmaceuticals Pvt Ltd

Otira Pharmaceuticals Pvt Ltd - chemicals in Medak, Telangana, India. Directors, charges & compliance details.
CIN U24239TG1987PTC007723 Incorporated 25 August 1987 ROC Hyderabad HQ Medak, Telangana, India
Struck Off Private Limited Company chemicals
Data last updated
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹2 Cr
Issued & subscribed
Satisfied charges
₹9.52 Cr
No open charges
Company age
39 yrs
Est. 1987
Directors on board
2
As per MCA filings
Last financials
Mar 2013
Balance sheet date
Last AGM
20 Jul 2013
Annual general meeting
Company status
Struck Off
MCA master data

About Otira Pharmaceuticals Pvt Ltd

Data last updated:

Otira Pharmaceuticals Pvt Ltd was a private limited company based in Medak, Telangana, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the speciality chemicals segment of the chemicals sector. It was incorporated on 25 August 1987.

The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG1987PTC007723.

The company had an authorised share capital of ₹2 Cr and a paid-up capital of ₹2 Cr. It was led by directors Ravikumar and Boini Venkatesh.

Its last annual general meeting (AGM) was held on 20 July 2013, and its latest financial statements are for the year ended 31 March 2013. The registered office was at Sy.No.660/E Bonthapally Village Jinnaram Mandal, Medak, Telangana, India – 502313.

As per MCA filings, the company had satisfied charges of ₹9.52 Cr on record. Court records list 15 cases involving the company, including 5 filed by the company and 10 filed against it; 2 cases are pending.

Company details

CIN U24239TG1987PTC007723
Registration Number 007723
Incorporation Date 25 August 1987
ROC Hyderabad
Listing Status Unlisted
Company Status Struck Off
Date of Last AGM 20 July 2013
Date of Balance Sheet 31 March 2013

CIN history

Otira Pharmaceuticals has one previous CIN (Corporate Identification Number): U24239AP1987PTC007723. The current CIN is U24239TG1987PTC007723, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24239TG1987PTC007723Current
U24239AP1987PTC007723Previous

Contact details

Otira Pharmaceuticals Pvt Ltd's registered office is in Medak, Telangana.

  • Registered Address
    Sy.No.660/E Bonthapally Village Jinnaram Mandal, Medak, Telangana, India – 502313
  • Industry
    Chemicals, Other Chemical Product, Manufacturing
Comprehensive company report
Otira Pharmaceuticals Pvt Ltd - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Otira Pharmaceuticals Pvt Ltd

FY 2013 filings available

Financial Statement Summary

MetricsFY 2012-13
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA
Profit Before Tax
Tax Expense
Net Profit (PAT)
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2012-13
Profitability
EBITDA Margin
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Otira Pharmaceuticals Pvt Ltd, buy the company report.

Board of directors of Otira Pharmaceuticals Pvt Ltd

Otira Pharmaceuticals has 2 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
RavikumarAdditional Director26 May 20179 Years 5 MonthsAs last reported
Boini VenkateshAdditional Director26 May 20179 Years 5 MonthsAs last reported

Charges & borrowings

Open charges
None
Satisfied charges
₹9.52 Cr
Breakdown by lending institutions
State Bank of India₹9.30 Cr
Andhra Pradesh State Financial Corporation₹0.13 Cr
The Anz Gridland Bank Plc₹0.09 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
06 Jun 201110296740State Bank of India₹9.3 CrSatisfied
23 May 198990120306The Anz Gridland Bank Plc₹8.5 LakhSatisfied
16 Sep 198890124674Andhra Pradesh State Financial Corporation₹13.46 LakhSatisfied

To see the full charge records of Otira Pharmaceuticals Pvt Ltd, buy the company report.

Total charge records: 3 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Otira Pharmaceuticals Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Otira Pharmaceuticals Pvt Ltd; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Otira Pharmaceuticals Pvt Ltd has 9 board changes on record since 2010: 2 appointments and 7 cessations. The latest: Vemula Swarna Kumari ceased to be Additional Director on 27 May 2017.

Ceased
Vemula Swarna Kumari ceased to be Additional Director.
Ceased
Vemula Vamsi Krishna ceased to be Additional Director.
Appointed
Boini Venkatesh was appointed as Additional Director.
Appointed
Ravikumar was appointed as Additional Director.
Charges
A charge registered on 06 Jun 2011 via Charge ID 10296740 with State Bank Of India was fully satisfied on 13 Mar 2017.
Ceased
Ravikumar ceased to be Additional Director.
Ceased
Vemula Rajendra Kumar ceased to be Additional Director.
AGM
Otira Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 20 Jul 2013 as per latest MCA records.
Filing
Otira Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2013 with Roc Hyderabad.
Charges
A charge with State Bank Of India of Rs. 9.30 Cr registered on 06 Jun 2011 with Charge ID 10296740 was modified on 20 Dec 2012.
Charges
A charge with State Bank Of India amounted to Rs. 9.30 Cr with Charge ID 10296740 was registered on 06 Jun 2011.
Ceased
Vinita Bajaj ceased to be Director.

8 earlier events are in the company report.

Frequently asked questions

Otira Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.

Otira Pharmaceuticals was a private limited company based in Medak, Telangana, India. The company worked in other chemical product, within the chemicals industry. It was incorporated on 25 August 1987 and is registered under CIN U24239TG1987PTC007723. The company has been struck off by the Registrar of Companies and is no longer operational.

Otira Pharmaceuticals had 2 directors:

The CIN (Corporate Identification Number) of Otira Pharmaceuticals is U24239TG1987PTC007723. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The registered office of Otira Pharmaceuticals is at Sy.No.660E Bonthapally Village Jinnaram Mandal, Medak, Telangana, India – 502313.

Otira Pharmaceuticals was incorporated on 25 August 1987. It is registered with the Registrar of Companies, Hyderabad.

The latest financial statements of Otira Pharmaceuticals on record with the MCA are for the year ended 31 March 2013. Its last annual general meeting was held on 20 July 2013. Year-wise statements from 2015 are in the company report.

Otira Pharmaceuticals operated in the chemicals industry, in the other chemical product segment. It worked in this industry before it was struck off.

Otira Pharmaceuticals has 15 court cases on record: 5 filed by the company and 10 filed against it. 2 are pending. Most are in the district courts.

Vemula Swarna Kumari ceased to be Additional Director on 27 May 2017. Vemula Vamsi Krishna ceased to be Additional Director on 27 May 2017. Boini Venkatesh was appointed as Additional Director on 26 May 2017. Otira Pharmaceuticals has 9 board changes on record in total.